Copyright
©The Author(s) 2015.
World J Gastroenterol. Jan 28, 2015; 21(4): 1222-1233
Published online Jan 28, 2015. doi: 10.3748/wjg.v21.i4.1222
Published online Jan 28, 2015. doi: 10.3748/wjg.v21.i4.1222
Table 1 Demographic and clinicopathologic characteristics of patients n (%)
Follow up (yr) | Total (n = 201) | P value | ||
Before 2008 (n = 127) | 2008-2010 (n = 74) | |||
Demographics | ||||
Age (yr), mean ± SD | 56.7 ± 12.7 | 54.7 ± 10.3 | 56.0 ± 11.9 | 0.2701 |
Gender | ||||
Female | 36 (28.3) | 25 (33.8) | 61 (30.3) | 0.4192 |
Male | 91 (71.7) | 49 (66.8) | 140 (69.7) | |
Clinicopathologic characteristics | ||||
Pathological type | ||||
AdenoCa | 92 (72.4) | 39 (52.7) | 131 (65.2) | 0.0012 |
Signet ring | 33 (26.0) | 31 (41.9) | 64 (31.8) | |
Squamous | 2 (1.6) | 0 | 0 | |
Mucinous | 0 | 4 (5.4) | 4 (2.0) | |
Tumor size | ||||
< 5 cm | 49 (43.0) | 28 (47.5) | 77 (44.5) | 0.0552 |
5-10 cm | 60 (52.6) | 23 (39.0) | 83 (48.0) | |
> 10 cm | 5 (4.4) | 8 (13.6) | 13 (7.5) | |
Tumor location | ||||
Antrum | 56 (44.8) | 37 (51.4) | 93 (47.2) | 0.2492 |
Cardia | 29 (23.2) | 15 (20.8) | 44 (22.3) | |
Corpus | 37 (29.6) | 15 (20.8) | 52 (26.4) | |
> 1 region | 3 (2.4) | 5 (6.9) | 8 (4.1) | |
Differentiation | ||||
Well | 2 (1.7) | 1 (1.8) | 3 (1.7) | 0.8852 |
Moderate | 41 (35.3) | 18 (31.6) | 59 (34.1) | |
Poor | 73 (62.9) | 38 (66.7) | 111 (64.2) | |
Surgery type | ||||
Total gastrectomy | 64 (50.4) | 37 (50.0) | 101 (50.2) | 0.9572 |
Subtotal gastrectomy | 63 (49.6) | 37 (50.0) | 100 (49.8) | |
Surgical margin | ||||
Negative | 114 (89.8) | 61 (82.4) | 175 (87.1) | 0.1352 |
Positive | 13 (10.2) | 13 (17.6) | 26 (12.9) | |
Vascular involvement | 81 (64.8) | 58 (80.6) | 139 (70.6) | 0.0333 |
Perineural involvement | 80 (64.0) | 52 (72.2) | 132 (68.4) | 0.4263 |
TM stage | ||||
T1T2 | 40 (31.5) | 23 (31.1) | 63 (31.3) | 0.9512 |
T3T4 | 87 (68.5) | 51 (68.9) | 138 (68.7) | |
Nodal stage | ||||
N0 | 30 (24.2) | 12 (16.7) | 42 (21.4) | 0.2542 |
N1 | 55 (44.4) | 26 (36.1) | 81 (41.3) | |
N2 | 26 (21.0) | 24 (33.3) | 50 (25.5) | |
N3 | 13 (10.5) | 10 (13.9) | 23 (11.7) | |
AJCC 2002 nodal stage | ||||
N0 | 32 (25.2) | 14 (18.9) | 46 (22.9) | 0.3642 |
N1 | 62 (48.8) | 35 (47.3) | 97 (48.3) | |
N2 | 26 (20.5) | 15 (20.3) | 41 (20.4) | |
N3 | 6 (4.7) | 8 (10.8) | 14 (7.0) | |
NX | 1 (0.8) | 2 (2.7) | 3 (1.5) | |
AJCC 2010 nodal stage | ||||
N0 | 32 (25.2) | 14 (18.9) | 46 (22.9) | 0.2312 |
N1 | 32 (25.2) | 12 (16.2) | 44 (21.9) | |
N2 | 31 (24.4) | 23 (31.1) | 54 (26.9) | |
N3a | 25 (19.7) | 15 (20.3) | 40 (19.9) | |
N3b | 6 (4.7) | 8 (10.8) | 14 (7.0) | |
Nx | 1 (0.8) | 2 (2.7) | 3 (1.5) | |
Dissected lymph nodes, median (IQR) | 15 (13.0) | 17.5 (13.0) | 16 (14.0) | 0.2164 |
LN1 | ||||
< 15 | 66 (52.4) | 30 (40.5) | 96 (48.0) | 0.1062 |
≥ 16 | 60 (47.6) | 44 (59.5) | 104 (52.0) | |
LN2 | ||||
< 10 | 38 (30.2) | 18 (24.3) | 56 (28.0) | 0.3752 |
≥ 11 | 88 (69.8) | 56 (75.7) | 144 (72.0) | |
Involved lymph nodes, median (IQR) | 2 (6.0) | 4 (7.0) | 3 (6.0) | 0.0734 |
- Citation: Ozden S, Ozgen Z, Ozyurt H, Gemici C, Yaprak G, Tepetam H, Mayadagli A. Survival in gastric cancer in relation to postoperative adjuvant therapy and determinants. World J Gastroenterol 2015; 21(4): 1222-1233
- URL: https://www.wjgnet.com/1007-9327/full/v21/i4/1222.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i4.1222